Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial

Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial

Landmark Australian study opens new possibilities for children with aggressive brain tumors and signals opportunity for Canada and USA. CALGARY, AB and BRISBANE, Australia , Feb. 5, 2026 /PRNewswire/ -- Providence Therapeutics, a Canadian...

menu
menu